Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.16 per share a year ago

Installed Building Products (IBP) Q2 Earnings and Revenues Surpass Estimates
Installed Building Products (IBP) Q2 Earnings and Revenues Surpass Estimates

Installed Building Products (IBP) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $2.95 per share a year

Hertz Global Holdings, Inc. (HTZ) Reports Q2 Loss, Beats Revenue Estimates
Hertz Global Holdings, Inc. (HTZ) Reports Q2 Loss, Beats Revenue Estimates

Hertz Global Holdings, Inc. (HTZ) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.34 per share a year ago

Ocugen (OCGN) Reports Q2 Loss, Beats Revenue Estimates
Ocugen (OCGN) Reports Q2 Loss, Beats Revenue Estimates

Ocugen (OCGN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.05 per share a year ago. These figures are

Shift4 Payments (FOUR) Q2 Earnings and Revenues Beat Estimates
Shift4 Payments (FOUR) Q2 Earnings and Revenues Beat Estimates

Shift4 Payments (FOUR) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.1 per share a year ago. These

Payoneer Global Inc. (PAYO) Misses Q2 Earnings Estimates
Payoneer Global Inc. (PAYO) Misses Q2 Earnings Estimates

Payoneer Global Inc. (PAYO) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago

Frontdoor (FTDR) Q2 Earnings and Revenues Top Estimates
Frontdoor (FTDR) Q2 Earnings and Revenues Top Estimates

Frontdoor (FTDR) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.63 per share a year ago. These figures

Fox Corporation (FOX) Surpasses Q4 Earnings and Revenue Estimates
Fox Corporation (FOX) Surpasses Q4 Earnings and Revenue Estimates

Fox Corporation (FOX) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.27 per share a year ago. These

Fox (FOXA) Q4 Earnings and Revenues Surpass Estimates
Fox (FOXA) Q4 Earnings and Revenues Surpass Estimates

Fox (FOXA) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.27 per share a year ago. These figures are

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $0.57 per share a year

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.28 per share a year ago. These

Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates

Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.33 per share a year ago. These

Monte Rosa Therapeutics (GLUE) Reports Q2 Loss, Misses Revenue Estimates
Monte Rosa Therapeutics (GLUE) Reports Q2 Loss, Misses Revenue Estimates

Monte Rosa Therapeutics (GLUE) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.15 per share a year ago. These

FrontView REIT, Inc. (FVR) Q2 FFO Meet Estimates
FrontView REIT, Inc. (FVR) Q2 FFO Meet Estimates

FrontView REIT, Inc. (FVR) came out with quarterly funds from operations (FFO) of $0.33 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.32 per share a year ago

Delcath Systems, Inc. (DCTH) Tops Q2 Earnings and Revenue Estimates
Delcath Systems, Inc. (DCTH) Tops Q2 Earnings and Revenue Estimates

Delcath Systems, Inc. (DCTH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.16 per share. This compares to earnings of $0.07 per share a

EuroDry (EDRY) Beats Q2 Earnings and Revenue Estimates
EuroDry (EDRY) Beats Q2 Earnings and Revenue Estimates

EuroDry (EDRY) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to a loss of $1.1 per share a year ago. These figures are

Driven Brands Holdings Inc. (DRVN) Q2 Earnings and Revenues Lag Estimates
Driven Brands Holdings Inc. (DRVN) Q2 Earnings and Revenues Lag Estimates

Driven Brands Holdings Inc. (DRVN) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.36 per share a year

Genius Sports Limited (GENI) Reports Q2 Loss, Tops Revenue Estimates
Genius Sports Limited (GENI) Reports Q2 Loss, Tops Revenue Estimates

Genius Sports Limited (GENI) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.21 per share a year ago. These

Datadog (DDOG) Q2 Earnings and Revenues Surpass Estimates
Datadog (DDOG) Q2 Earnings and Revenues Surpass Estimates

Datadog (DDOG) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.46 per share a year ago. These figures

CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates
CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates

CG Oncology, Inc. (CGON) came out with a quarterly loss of $0.9 per share versus the Zacks Consensus Estimate of a loss of $0.7. This compares to a loss of $0.54 per share a year ago. These figures